AdAlta presents at Investor Summit
Read MoreNews & Media – old
AdAlta presents at Twilight Investor Briefing
Read MoreAdAlta Rights Offer webinar recording, Wednesday 3 May 2023
Read MoreBioshares: AdAlta prioritises IV formulation for AD-214
Read MoreLooking back on Pulmonary Fibrosis Awareness Month 2020
Read MoreCEO, Tim Oldham podcast interview with Australian Shareholders’ Association
Read MoreAdAlta to present on 29 July at IRD Invest
Read MoreMoving AD-214 into the clinic: AdAlta’s coming of age moment
Read MoreVideo: CEO, Dr Tim Oldham talks about AdAlta becoming a clinical stage company
Read More
